|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Blood screening by nucleic acid amplification technology:current issues,future challenges显示文摘 | Gallarda JL Dragon E | | 0，，01： | 1 |
| 2 | Blood screening by nucleic acid amplification technology: current issues, future challenges显示文摘 | Gallarda JL Dragon E | 2000 | Mol Diag2000，5，1： | 1 |
| 3 | Hope and spirituality among patients with chronic kidney disease undergoing hemodialysis: a correlational study显示文摘 | OTYAVIANI A C SOUZA E N DRAGON C | 2014 | Rev Latino Am Enferma- gem2014，22，2： | 1 |
| 4 | A Large Nueleolar U3 Ribonueleoprotein Required for 18S Ribosomal RNA Biogenesis 显示文摘 | Dragon F Gallagher J E Compagnone-Post P A | 2002 | Nature2002，417，： | 1 |
| 5 | Blood screening by nucleic acid amplication technology: future challenges显示文摘 | Gallarda JL Dragon E | 2000 | Mol Diag2000，5，： | 1 |
| 6 | Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis显示文摘 | Kessler HH Pierer K Dragon E | 1998 | B Chin Diagn Virol1998，9，： | 1 |
| 7 | High pre-treatment serum hepatitis B virus titer predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation显示文摘 | Mutimer D Pillay D Dragon E | 1999 | J Hepatol1999，30，4： | 1 |
| 8 | Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B 显示文摘 | Kessler HH Pierer K Dragon E | 1998 | Chin Diagn Virol1998，9，： | 1 |
| 9 | Blood screening by nucleic acid amplification technology:current issues,future challenges显示文摘 | Gallarda JL Dragon E | | 0，，01： | 1 |
| 10 | Blood screening by nucleic acid amplification technology: current issues, future challenges显示文摘 | GALLARDA J L DRAGON E | 2000 | Mol Diagn2000，5，： | 1 |
| 11 | Blood screening by nucleic acid amplification technology:current issues,future challenges显示文摘 | GallardaJL Dragon E | 2000 | Mol Diagn2000，5，1： | 1 |
| 12 | Blood screening by nucleic acid amplification technology: current issues, future chal- lenges显示文摘 | Gallarda JL Dragon E | 2000 | Mol Diag2000，5，1： | 1 |
| 13 | Blood screening by nucleic acid amplification technology cuttent,future challenges显示文摘 | Callarda JL Dragon E | | 0，，01： | 1 |
| 14 | Blood screening by nucleic acid amplification technology: current issues, future challenges 显示文摘 | Gallarda JL Dragon E | 2000 | Mol Diagn2000，5，1： | 1 |
| 15 | Precision micromachining with pulsed green lasers 显示文摘 | CHANG J J WAMER B E DRAGON E P | 1998 | Journal of Laser Applications1998，，10： | 1 |
| 16 | Improvement of ethanol productivity in a high-gravity brewing at pilot plant scale显示文摘 | Dragone G Silva D P Almeida e Silva J B | 2003 | Biotechnology Letters2003，25，： | 1 |
| 17 | High pre-treatment serum hepatitis B virus titer predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation显示文摘 | Mutimer D Pillay D Dragon E | 1999 | J Hepatol1999，30，4： | 1 |
| 18 | Blood screening by nucleic acid amplification technology : current issues, future challenges 显示文摘 | Gallarda JI Dragon E | 2000 | Mol Diag2000，5，1： | 1 |
| 19 | Blood screening by nucleic acid amplification technology: current issues, future challenges显示文摘 | Gallarda JL Dragon E | 2000 | Mol Diag2000，5，1： | 1 |
| 20 | Blood screening by nucleic acid amplification technology:current issues,future challenges显示文摘 | Gallarda JL Dragon E | | 0，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员